Michelle Smith was told she had eczema as a teenager but her skin condition gradually worsened over years - until doctors ...

Patients with HER2-positive breast cancer in the FLAMINGO-01 phase 3 clinical trial are seeing a continued reduction in recurrence rates, Greenwich LifeSciences, Inc. has reported. The preliminary ...

A growing field of research suggests that some medical treatments, such as cancer therapy or vaccines, might be more ...

Michelle Smith was told she had eczema as a teenager, but as the years went on her skin became 'so much worse' - until ...

Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the 'Company'), a clinical-stage biopharmaceutical company focused on its Phase ...

Phase 2 Study Demonstrated 73% clinical Clearance in the 200-µg Arm suggests that ~3 out of 4 treated lesions may allow patients to avoid ...

Phase 2 Study Demonstrated 73% clinical Clearance in the 200-µg Arm suggests that ~3 out of 4 treated lesions may allow ...

Patti Hansen's family helped the iconic supermodel ring in her 70th birthday on Tuesday with touching tributes in celebration ...

The Company will issue a release after the oral presentation that will include the 5-year OS data, which is the longest OS ...

Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01 ...

Intensity Therapeutics Inc. INTS on Thursday provided an update on the INVINCIBLE-4 Study. The INVINCIBLE-4 study is a Phase ...

Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the 'Company'), a clinical-stage biopharmaceutical company focused on its Phase ...